MondayNov 29, 2021 1:04 pm

10th Annual Pharmaceutical Regulatory Operations & Submissions Conference

Date: December 1-2, 2021 Venue: Virtual Event Q1 Production’s premier event platform offers a refreshing and unparalleled virtual experience. Thoughtfully designed and customizable networking features foster a sense of collaboration and discussion, allowing attendees to make direct connections. This program offers three half-day modules to maximize retention and engagement.  Methods of application and influence of technological advancements AI Integration Automation Possibilities Regulatory operations teams and developing strategic skill sets Bridging the gap between associates at the junior and senior levels Dealing with changes in regulatory requirements and global considerations Keeping up with general industry developments Special considerations regarding emerging markets …

Continue Reading

MondayNov 29, 2021 1:00 pm

NCIA’s 7th Annual Cannabis Business Summit & Expo to Host San Francisco Mayor, London Breed

NCIA’s 7th Annual Cannabis Business Summit & Expo takes place December 15-17, 2021, at the Moscone Center in San Francisco. The event will showcase more than 80 educational sessions, 125-plus industry speakers, and hundreds of exhibitors under a single roof San Francisco Mayor, London Breed, will deliver welcome remarks at the conference on Thursday, December 16th at 10 a.m. PST. The Mayor’s appearance at the conference comes as the city celebrates the 30th anniversary of Proposition P, which legalized the use of medical cannabis in San Francisco in 1991.  The National Cannabis Industry Association (“NCIA”), widely recognized as the oldest,…

Continue Reading

MondayNov 29, 2021 12:53 pm

The MoneyShow Canada Virtual Expo To Offer Latest Analysis And Expert Advice For Timely Investment Strategies

Date: November 30-December 2, 2021 Live Streaming Event Traders, shareholders, businesses, financial heads, and investment experts are invited to attend the MoneyShow Canada Virtual Expo being held from November 30- December 2, 2021, as a live streaming event. MoneyShow has been organizing conferences and seminars for over 40 years with a 100,000+ community of investors, financial heads, and businesses looking to gain knowledge and guidance about the latest investment tools, financial trends and opportunities from the stalwarts of the financial arena.  The event boasts of a productive platform where attendees can take stock of the trending market ideas, stock picks,…

Continue Reading

MondayNov 29, 2021 9:30 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Schedules November 29th for Q3 2021 Financials Release; November 30th for Earnings Discussion

RWB is set to release its Q3 financial results on November 29, 2021 A conference call will follow this release on November 30, 2021, at 5:00 PM ET to discuss these results, the company’s operations, upcoming events, and a Q&A session A replay of the call will be available for 90 days, starting three hours after the conclusion RWB is increasingly optimistic about its Q3 performance following growth in revenue from Q1 to Q2, along with strategic investments that would allow for Q3 growth Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) just announced that it will be releasing…

Continue Reading

MondayNov 29, 2021 9:30 am

RYAH Group Inc. (CSE: RYAH) Releases Overview of UK Cannabis Market

Market analysts place high hopes on the potential of the United Kingdom market Growing demand from patients and patient families brought the country’s medical cannabis program to a tipping point RYAH is committed to providing valuable insight and transforming patient care through big data and artificial intelligence After three years of medical cannabis being legal in the United Kingdom, the country has a total of only three patients with a prescription in the entire public system, noted a recent blog from RYAH Group (CSE: RYAH). The article noted that many more patients receive cannabis-derived medications, including flower and cannabis oil,…

Continue Reading

MondayNov 29, 2021 9:30 am

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Expands Marketing Reach, Offers Discounts, Through New Subscription Service

Plant-based food consumers are a growing market sector, increasing their purchases at a rate almost 2.5 times the growth of the overall foods market during the past two years Plant-based community brand builder PlantX Life Inc. is becoming a growing global presence as part of its efforts to become a one-stop shopping source of products and information about the plant-based lifestyle PlantX has physical store presence in Canada and the U.S., as well as one in Israel that will open before the end of the year The company’s e-commerce platform recently added a subscription service that caters to recurring customer…

Continue Reading

MondayNov 29, 2021 9:00 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Psilocybin Drug Program for the Treatment of Pain and Eating Disorders Takes On Special Meaning Leading Up To The Holidays

People with eating disorders know all about the difficulties faced during holiday celebrations and their association with heavy eating The fall-winter holiday season can also adversely affect people suffering from certain chronic pains, as temperatures and pressure changes can increase pain sensitivity Tryp is looking to help alleviate problems associated with eating disorders and chronic pain through its psilocybin-based drug program that focuses on conditions with high unmet needs The company has submitted several IND applications for Phase 2a studies evaluating TRP-8802’s effectiveness in patients with chronic pain and select eating disorders There is no denying that food is a…

Continue Reading

MondayNov 29, 2021 9:00 am

Insurtech Market Seen as a Major Driver for Big Data and Mobile Tech Innovator FingerMotion Inc. (FNGR)

U.S.-based FingerMotion is a technology innovator focused on smart communication applications in China’s mobile-hungry billion-plus population The company’s big data services are relatively new in development but already play a significant role in the insurtech industry’s global growth trends While most of FingerMotion’s revenues are derived from its SMS and MMS products, executives anticipate its big data services will eventually be the company’s largest driver of profits The insurtech industry has already generated record annual deal-making this year as of the third quarter, outpacing all of 2020 by 48 percent The insurtech industry has turned 2021 into a record year…

Continue Reading

MondayNov 29, 2021 9:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q1 2022 Financial Results, Business Update Showing Positive Momentum Across All Its Programs

InMed Pharmaceuticals released Q1 2022 financial results in which it reported a year-on-year increase in research and development expenses primarily due to increased activities related to INM-755 clinical trials The company’s cash, cash equivalents, and short-term investments also grew quarter over quarter from $7.4 million to $15.4 million Following the closing of BayMedica’s acquisition, the integrated teams are working together with a focus on launching selected rare cannabinoids, growing revenue, and expanding sales InMed has commenced Phase 2 clinical trial of INM-755 (cannabinol) cream for the treatment of a group of rare skin disorders Preclinical data of INM-088, the company’s…

Continue Reading

WednesdayNov 24, 2021 12:17 pm

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Looking to Change Narrative in Treating Fibromyalgia, Chronic Pain

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) is looking to transform the existing treatment of fibromyalgia, along with other forms of chronic pain, and relieve the suffering of millions of patients. To achieve this, the company is relying on the guidance of its scientific advisory board (“SAB”) as well as research-based work conducted in partnership with the University of Michigan (“U-M”). “According to Tryp’s internal analysis, over 4 million people suffer from fibromyalgia in the United States. Globally, the condition affects an estimated 3-6% of the population (roughly 232-465 million people). Unfortunately, despite the disease afflicting millions, researchers have not yet…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered